PT Siloam International Hospitals TbkFRA:2LS +1.04%95 Return-on-Tangible-Equity is 12.10% as of Mar. 2026, which is 58% above its 10-year median of 7.67. GuruFocus rates FRA:2LS with a GF Score™ of 95/100 and a GF Value™ of €0.13 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 581 Healthcare Providers & Services companies, PT Siloam International Hospitals Tbk ranks better than 56.45% on this metric.
The historical rank and industry rank for PT Siloam International Hospitals Tbk's Return-on-Tangible-Equity or its related term are showing as below:
FRA:2LS'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -6.02 Med: 7.67 Max: 17.47
Current: 13.06
During the past 13 years, PT Siloam International Hospitals Tbk's highest Return-on-Tangible-Equity was 17.47%. The lowest was -6.02%. And the median was 7.67%.
FRA:2LS's Return-on-Tangible-Equity is ranked better than 56.45% of 581
companies
in the Healthcare Providers & Services industry
Industry Median: 9.93
vs FRA:2LS: 13.06
PT Siloam International Hospitals Tbk (FRA:2LS) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
PT Siloam International Hospitals Tbk Return-on-Tangible-Equity Related Terms
PT Siloam International Hospitals Tbk Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Siloam International Hospitals Tbk Return-on-Tangible-Equity Chart
FRA:2LS vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, PT Siloam International Hospitals Tbk's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Siloam International Hospitals Tbk Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Siloam International Hospitals Tbk's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where PT Siloam International Hospitals Tbk's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 12.10% mean?
PT Siloam International Hospitals Tbk (FRA:2LS) has a Return-on-Tangible-Equity of 12.10% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on PT Siloam International Hospitals Tbk and its competitors. This is 58% above median its historical median of 7.67. According to the industry distribution chart, PT Siloam International Hospitals Tbk ranks #253 out of 581 companies in the Healthcare Providers & Services industry, placing it in the top 43.5%.
Is PT Siloam International Hospitals Tbk's Return-on-Tangible-Equity too high?
PT Siloam International Hospitals Tbk's current Return-on-Tangible-Equity of 12.10% is 58% above median its 10-year median of 7.67. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 9.93. PT Siloam International Hospitals Tbk's value of 12.10% is 21.9% above this industry median. Based on the distribution chart, PT Siloam International Hospitals Tbk ranks #253 out of 581 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, PT Siloam International Hospitals Tbk has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Siloam International Hospitals Tbk's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Siloam International Hospitals Tbk ranks #253 out of 581 companies for Return-on-Tangible-Equity. This puts PT Siloam International Hospitals Tbk in the upper half of its industry. The industry median Return-on-Tangible-Equity is 9.93. PT Siloam International Hospitals Tbk's value of 12.10% is 21.9% above this benchmark. While the company's 10-year median is 7.67 vs. the industry median of 9.93, PT Siloam International Hospitals Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 9.93, based on 581 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Siloam International Hospitals Tbk's current Return-on-Tangible-Equity of 12.10% is 21.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on PT Siloam International Hospitals Tbk and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 9.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Siloam International Hospitals Tbk's current Return-on-Tangible-Equity is 12.10%, which is 58% above median its own 10-year median of 7.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Siloam International Hospitals Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Siloam International Hospitals Tbk (FRA:2LS) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.13, compared to a current price of €0.10 — trading 25% below its estimated fair value. The current Return-on-Tangible-Equity is 12.10%, which is 58% above median its 10-year median of 7.67 and 21.9% above the Healthcare Providers & Services industry median of 9.93. PT Siloam International Hospitals Tbk's overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For PT Siloam International Hospitals Tbk (FRA:2LS), the current Return-on-Tangible-Equity is 12.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Siloam International Hospitals Tbk (FRA:2LS) Overvalued in 2026?
Based on GuruFocus' analysis, PT Siloam International Hospitals Tbk stock appears to be undervalued.
The current stock price of €0.10 is trading 25% below its estimated GF Value™ of €0.13.
GuruFocus considers PT Siloam International Hospitals Tbk to be Modestly Undervalued.
Key valuation signals for FRA:2LS:
Return-on-Tangible-Equity: 12.10% (58% above median its 10-year median of 7.67)
GF Value™: €0.13 vs. price of €0.10 (25% below fair value)
Industry Position: 21.9% above the Healthcare Providers & Services median (#253 of 581)
No single metric tells the full story. See the FRA:2LS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Siloam International Hospitals Tbk Business Description
PT Siloam International Hospitals Tbk operates a network of hospitals in Indonesia. Its hospitals are located in the Greater Jakarta area and across Java, Sumatra, Kalimantan, Sulawesi, Bali, Nusa Tenggara, Ambon, and other areas across Indonesia, along with several Siloam Clinics. The company offers an integrated, one-stop care ecosystem designed to provide comprehensive healthcare services, spanning examination, diagnosis, clinical management, rehabilitation, and health education. Additionally, it offers special clinical services in the following segments, including neurosciences, neurology, digestive, cardiac, orthopedic, etc., by running the Center of Excellence and specialty centers. The company generates the majority of its revenue by offering hospitalization and outpatient services.
95GF Score
Get the complete analysis for FRA:2LS
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2LS has been successfully added to your 
